Covered recipient · General Payments record
ARTHUR DAVID
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$3,630.44
- Reported across 176 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $711.94 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $337.79 | 20 |
| Braeburn Inc. | $89.99 | 2 |
| Orexo US, Inc. | $86.51 | 4 |
| Exact Sciences Corporation | $44.37 | 2 |
| Indivior Inc. | $39.53 | 2 |
| Alkermes, Inc. | $32.39 | 1 |
| Abbott Laboratories | $23.30 | 1 |
| AppliedVR Inc | $21.67 | 1 |
| Novo Nordisk AS | $21.16 | 1 |
| Lilly USA, LLC | $15.23 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $23.30 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124912642 | CMS |
| ABBVIE INC. | $19.38 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103605344 | CMS |
| ABBVIE INC. | $7.84 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103605346 | CMS |
| ABBVIE INC. | $18.77 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103605348 | CMS |
| ABBVIE INC. | $26.14 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103605350 | CMS |
| ABBVIE INC. | $11.77 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103605352 | CMS |
| ABBVIE INC. | $19.75 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103605354 | CMS |
| ABBVIE INC. | $19.20 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103605356 | CMS |
| ABBVIE INC. | $17.84 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103605358 | CMS |
| ABBVIE INC. | $18.29 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103605360 | CMS |
| ABBVIE INC. | $20.68 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103605362 | CMS |
| ABBVIE INC. | $16.29 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103605364 | CMS |
| ABBVIE INC. | $5.24 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103605366 | CMS |
| ABBVIE INC. | $28.26 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103605368 | CMS |
| ABBVIE INC. | $22.69 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103605370 | CMS |
| ABBVIE INC. | $18.30 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103605372 | CMS |
| ABBVIE INC. | $7.23 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103605374 | CMS |
| ABBVIE INC. | $15.06 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103605376 | CMS |
| ABBVIE INC. | $8.98 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103605378 | CMS |
| ABBVIE INC. | $29.34 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103605380 | CMS |
| ABBVIE INC. | $6.74 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103605382 | CMS |
| Alkermes, Inc. | $32.39 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120487336 | CMS |
| AppliedVR Inc | $21.67 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151396068 | CMS |
| Braeburn Inc. | $73.75 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125599145 | CMS |
| Braeburn Inc. | $16.24 | 06/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125599143 | CMS |
| Exact Sciences Corporation | $18.15 | 06/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114627642 | CMS |
| Exact Sciences Corporation | $26.22 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114627646 | CMS |
| Indivior Inc. | $17.11 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144526492 | CMS |
| Indivior Inc. | $22.42 | 11/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144526494 | CMS |
| Lilly USA, LLC | $15.23 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136049211 | CMS |
| Novo Nordisk Inc | $21.16 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097681037 | CMS |
| Orexo US, Inc. | $23.74 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136176029 | CMS |
| Orexo US, Inc. | $16.59 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136178644 | CMS |
| Orexo US, Inc. | $23.72 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136176523 | CMS |
| Orexo US, Inc. | $22.46 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136176031 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.